Infectious Diseases Meetings promises to provide a forum for the exchange of ideas between the academic, business, clinical and pharmaceutical communities to develop an integrative understanding of pathogenesis and strategies for infectious diseases. Over the course of the Infectious Diseases Meetings participants will receive exclusive access to actively participate in engaging exchanges with leading microbiologist’s experts and expand professional networks from around the world.
These International Meetings include symposia, workshops, keynote lectures, oral and poster presentations and exhibits.
The Scientific Sessions of Infectious Diseases Meetings offer microbiologists, virologists, bacteriologists, physicians, young researchers and health care professionals the exclusive opportunity to share knowledge and learn about the significant advances in bacteriology, virology, microbiology, parasitology, mycology, rare diseases, communicable diseases etc.
Globally it is reported that the infectious diseases point-of-care testing (POCT) market is set to rise to over $1.17 billion by 2022, represents a compound annual growth rate of 7.7%, which are common and the top causes of environment-related deaths. The specificity and sensitivity achieved with the currently available lateral flow technologies at the POC is, at present, inferior to those achievable in central labs utilizing nucleic acid methods.
Reflecting this imperative Meetings International creates a unique platform conducting Endocrinology and Diabetes Meetings across Asia reuniting the world’s eminent scientists to unlock the mysteries of eradicating and infectious diseases.